Aclarion announces expansion plans with radnet affiliates in new york and new jersey

Broomfield, colo., march 06, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today plans to expand nociscan access across key markets in new york and new jersey.
ACON Ratings Summary
ACON Quant Ranking